Stephen Michael Dent, MD
NPI 1215943139ActiveIndividual· Otolaryngology· Encinitas, CA
Otolaryngology (MD) in Encinitas, California, trained at University of Texas Medical Branch at Galveston (class of 2004). 368 Medicare patients in 2024, $165,655 paid; nearly all of their 251 Part D prescriptions were generic (94%). Genzyme Corporation was the largest of 4 companies reporting payments in 2025, $306.32 in all, mostly food and beverage.
Overview
| NPI | 1215943139 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | MD |
| Sole proprietor | No |
| NPI issued | Jul 31, 2006 |
| Last updated in NPPES | Jul 29, 2016 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Otolaryngology Primary | 207Y00000X | A96200 | CA |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Nov 10, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 11, 2026 | No match | — |
| New York OMIG · Nov 11, 2026 | No match | — |
| Ohio Medicaid · Nov 11, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 11, 2026 | No match | — |
| Washington HCA · Nov 11, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Otolaryngology (CA) |
|---|---|
| Accepts assignment | Yes (participating) |
Medicare services in 2024
| Medicare patients | 368 |
|---|---|
| Services billed | 1,830 across 67 procedure codes |
| Paid by Medicare | $165,655 |
Part D prescriptions in 2024
| Prescriptions (claims) | 251 · 336 30-day fills |
|---|---|
| Patients | 117 |
| Total drug cost | $18,853 |
| Generic share | 94% of claims |
Education and affiliations
| Medical school | University of Texas Medical Branch at Galveston |
|---|---|
| Graduation year | 2004 |
| Medicare specialty | Otolaryngology |
Medical group
- Stephen Dent MD IncCarlsbad, CA · 5 clinicians
Hospital affiliation
- Scripps Memorial Hospital - EncinitasEncinitas, CA
Industry payments (Open Payments)
- 2025$306.32 · 11 payments from 4 companies
- 2024$418.22 · 15 payments from 5 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Genzyme Corporation | $196.88 | 6 |
| Glaxosmithkline, LLC. | $74.65 | 3 |
| Itamar Medical Inc | $18.27 | 1 |
| Astrazeneca Pharmaceuticals LP | $16.52 | 1 |
What the 2025 payments were for
- Food and Beverage$306.32 · 11 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records